UI Hospitals and Clinics
Cupid 2b: Enzyme Replacement Therapy for Advanced Heart Failure
A Phase 2b, Double-Blind, Placebo-Controlled, Multinational, Multicenter, Randomized Study Evaluating the Safety and Efficacy of Intracoronary Administration of MYDICAR® (AAV1/SERCA2a) in Subjects With Heart Failure. The purpose of this trial is to assess whether MYDICAR can reduce the frequency and/or delay heart failure related hospitalizations in persons with advanced heart failure when added to their maximal and optimized therapy.
Please refer to www.clinicaltrials.gov identifier NCT01643330
for more information.
Cardiomyopathy Treatment Program
Cynthia Larew, RN BSN
We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.